Peter David Suzdak Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter David Suzdak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter David Suzdak. Peter David Suzdak is Chief Executive Officer in REXAHN PHARMACEUTICALS, INC. ($RNN) and Director in AEOLUS PHARMACEUTICALS, INC. ($INCR.OB).
Latest Insider Trading Transactions of Peter David Suzdak
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
Mar 02 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Buy | M | 0.00 | 6,250 | 0 | 22,250 | 16 K to 22.3 K (+39.06 %) |
Jan 30 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 2.29 | 112,271 | 257,101 | 112,271 | |
Aug 16 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Grant | A | 1.99 | 10,000 | 19,872 | 16,000 | 6 K to 16 K (+166.67 %) |
Jan 24 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
Jan 24 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.18 | 1,175,000 | 216,200 | 1,175,000 | |
Mar 21 2016 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Grant | A | 0.32 | 60,000 | 19,386 | 60,000 | 0 to 60 K |
Feb 01 2016 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.35 | 1,000,000 | 350,000 | 1,000,000 | |
Feb 01 2016 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.35 | 411,689 | 144,091 | 411,689 | |
Sep 23 2004 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 1.85 | 20,000 | 37,000 | 20,000 |
Page: 1